Dr. Helen Sjögren is a Principal Scientist at Ferring Pharmaceuticals in Denmark. She holds a MSc in chemical engineering and a PhD in physical chemistry both from Lund University. She has over 25 years of experience from the pharmaceutical industry whereof the last 15 years with pharmaceutical development of biologicals; process, formulation and drug delivery of proteins, peptides and viruses. She has previously worked at Sandoz in Germany and at AstraZeneca at various positions and locations in Sweden.